These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25976927)

  • 1. Parkinson's disease biomarkers program brain imaging repository.
    Ofori E; Du G; Babcock D; Huang X; Vaillancourt DE
    Neuroimage; 2016 Jan; 124(Pt B):1120-1124. PubMed ID: 25976927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NINDS Parkinson's disease biomarkers program.
    Rosenthal LS; Drake D; Alcalay RN; Babcock D; Bowman FD; Chen-Plotkin A; Dawson TM; Dewey RB; German DC; Huang X; Landin B; McAuliffe M; Petyuk VA; Scherzer CR; Hillaire-Clarke CS; Sieber BA; Sutherland M; Tarn C; West A; Vaillancourt D; Zhang J; Gwinn K;
    Mov Disord; 2016 Jun; 31(6):915-23. PubMed ID: 26442452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain SPECT can differentiate between essential tremor and early-stage tremor-dominant Parkinson's disease.
    Song IU; Park JW; Chung SW; Chung YA
    J Clin Neurosci; 2014 Sep; 21(9):1533-7. PubMed ID: 24814853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
    Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
    Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning.
    Severson KA; Chahine LM; Smolensky LA; Dhuliawala M; Frasier M; Ng K; Ghosh S; Hu J
    Lancet Digit Health; 2021 Sep; 3(9):e555-e564. PubMed ID: 34334334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
    Kang UJ; Goldman JG; Alcalay RN; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Rudolph A; Casaceli C; Andrews H; Gwinn K; Sutherland M; Kopil C; Vincent L; Frasier M
    Mov Disord; 2016 Jun; 31(6):924-32. PubMed ID: 27113479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Parkinson's Disease Developed from Essential Tremor.
    Ryu DW; Lee SH; Oh YS; An JY; Park JW; Song IU; Lee KS; Kim JS
    J Parkinsons Dis; 2017; 7(2):369-376. PubMed ID: 28409750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.
    Gwinn K; David KK; Swanson-Fischer C; Albin R; Hillaire-Clarke CS; Sieber BA; Lungu C; Bowman FD; Alcalay RN; Babcock D; Dawson TM; Dewey RB; Foroud T; German D; Huang X; Petyuk V; Potashkin JA; Saunders-Pullman R; Sutherland M; Walt DR; West AB; Zhang J; Chen-Plotkin A; Scherzer CR; Vaillancourt DE; Rosenthal LS
    Biomark Med; 2017 May; 11(6):451-473. PubMed ID: 28644039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for trials of neuroprotection in Parkinson's disease.
    Agarwal PA; Stoessl AJ
    Mov Disord; 2013 Jan; 28(1):71-85. PubMed ID: 22927101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of Parkinson's Disease: An Introduction.
    Titova N; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Essential tremor and Parkinson's disease: are they associated?].
    Labiano-Fontcuberta A; Benito-León J
    Rev Neurol; 2012 Oct; 55(8):479-89. PubMed ID: 23055430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data.
    Adeli E; Shi F; An L; Wee CY; Wu G; Wang T; Shen D
    Neuroimage; 2016 Nov; 141():206-219. PubMed ID: 27296013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing essential tremor from Parkinson's disease: clinical and experimental tools.
    Angelini L; Paparella G; Bologna M
    Expert Rev Neurother; 2024 Aug; 24(8):799-814. PubMed ID: 39016323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease prognostic scores for progression of cognitive decline.
    Gramotnev G; Gramotnev DK; Gramotnev A
    Sci Rep; 2019 Nov; 9(1):17485. PubMed ID: 31767922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model.
    Wang M; Li Z; Lee EY; Lewis MM; Zhang L; Sterling NW; Wagner D; Eslinger P; Du G; Huang X
    BMC Med Res Methodol; 2017 Sep; 17(1):147. PubMed ID: 28946857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of motor and non-motor features between essential tremor and tremor dominant Parkinson's disease.
    Kwon KY; Lee HM; Lee SM; Kang SH; Koh SB
    J Neurol Sci; 2016 Feb; 361():34-8. PubMed ID: 26810513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.